Cas 1250443-08-3,4-Piperidinecarboxylic acid, 4-fluoro-1-(phenylMethyl)-, ethyl ester

1250443-08-3

Post Buying Request

Basic information

Product Name: 4-Piperidinecarboxylic acid, 4-fluoro-1-(phenylMethyl)-, ethyl ester
Synonyms: 4-Piperidinecarboxylic acid, 4-fluoro-1-(phenylMethyl)-, ethyl ester;ethyl 1-benzyl-4-fluoropiperidine-4-carboxylate
CAS NO:1250443-08-3
Molecular Formula: C15H20FNO2
Molecular Weight: 265.3232032
EINECS: N/A
Product Categories: N/A
Mol File: 1250443-08-3.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-Piperidinecarboxylic acid, 4-fluoro-1-(phenylMethyl)-, ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-Piperidinecarboxylic acid, 4-fluoro-1-(phenylMethyl)-, ethyl ester(1250443-08-3)
EPA Substance Registry System: 4-Piperidinecarboxylic acid, 4-fluoro-1-(phenylMethyl)-, ethyl ester(1250443-08-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1250443-08-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1250443-08-3 Suppliers

Recommended suppliers

1250443-08-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1250443-08-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,0,4,4 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1250443-08:
(9*1)+(8*2)+(7*5)+(6*0)+(5*4)+(4*4)+(3*3)+(2*0)+(1*8)=113
113 % 10 = 3
So 1250443-08-3 is a valid CAS Registry Number.

1250443-08-3Upstream product

24228-40-8 N-benzyl isonipecotic acid ethyl ester

1250443-08-3Downstream Products

1250443-08-3Relevant academic research and scientific papers

FURO[3,2-d]PYRIMIDINE COMPOUNDS

-

Page/Page column 185-186, (2012/04/23)

The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1250443-08-3